NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹706 Cr | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr |
What is the latest Total Debt ratio of NATCO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹706 Cr |
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹363 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹404 Cr |
How is Total Debt of NATCO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹706 Cr | 158.66 | |
| Mar2025 | ₹273 Cr | -24.81 | |
| Mar2024 | ₹363 Cr | 120.12 | |
| Mar2023 | ₹165 Cr | -59.16 | |
| Mar2022 | ₹404 Cr | - | |
Compare Total Debt of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,598.4 Cr | -2.8% | -14.4% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2.8% |
-14.4% |
-3.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses